Evidence map›Paper›PMID 30087425›Full record

ArticleScientific reports2018

Active Transport of Peptides Across the Intact Human Tympanic Membrane.

Arwa Kurabi, Daniel Schaerer, Volker Noack, Marlen Bernhardt, Kwang Pak, Thomas Alexander, Jacob Husseman, Quyen Nguyen, Jeffrey P Harris, Allen F Ryan

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Microsurgical Robotic System for Myringoplasty: Feasibility Study.Laryngoscope investigative otolaryngology · 2025
    Article
  3. Endolysins: targetingFrontiers in microbiology · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Panel 1: Biotechnology, biomedical engineering and new models of otitis media.International journal of pediatric otorhinolaryngology · 2020
    Review
  11. Panel 3: Genomics, precision medicine and targeted therapies.International journal of pediatric otorhinolaryngology · 2020
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Arwa KurabiUniversity of California, San Diego, Division of Otolaryngology, Department of Surgery, La Jolla, CA, 92093, USA. akurabi@ucsd.edu.ORCID 0000-0001-5765-9496
Daniel SchaererUniversity of California, San Diego, Division of Otolaryngology, Department of Surgery, La Jolla, CA, 92093, USA.
Volker NoackRuhr-Universitat Bochum, Department of ENT, Bochum, NRW, Germany.
Marlen BernhardtUniversitätsklinik Würzburg, Department of ENT, Würzburg, 97070, Germany.
Kwang PakUniversity of California, San Diego, Division of Otolaryngology, Department of Surgery, La Jolla, CA, 92093, USA.
Thomas AlexanderUniversity of California, San Diego, Division of Otolaryngology, Department of Surgery, La Jolla, CA, 92093, USA.
Jacob HussemanUniversity of California, San Diego, Division of Otolaryngology, Department of Surgery, La Jolla, CA, 92093, USA.
Quyen NguyenUniversity of California, San Diego, Division of Otolaryngology, Department of Surgery, La Jolla, CA, 92093, USA.
Jeffrey P HarrisUniversity of California, San Diego, Division of Otolaryngology, Department of Surgery, La Jolla, CA, 92093, USA.
Allen F RyanUniversity of California, San Diego, Division of Otolaryngology, Department of Surgery, La Jolla, CA, 92093, USA.
University of California San Diego · USEuropean Neuroendocrine Tumor Society · DERuhr University Bochum · DE

Funding

Middle ear responses in Otitis MediaR01DC000129 · NIDCD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI RYAN, ALLEN F. · 1989 to 2021
$6.8M
Innovative therapy for diseases of the middle earR01DC012595 · NIDCD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI RYAN, ALLEN F. · 2012 to 2023
$3.3M
Establishment of an animal model of human-specific responses to middle ear infection.R03DC014801 · NIDCD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KURABI, ARWA · 2016 to 2018
$465k
Adjustable balloon implant for medialization thyroplastyF31DC012495 · NIDCD · UNIVERSITY OF WISCONSIN-MADISON · PI HOFFMAN, MATTHEW R · 2012 to 2012
$26k
Basic Mechanisms on Hearing Loss of Cochlear OriginI01BX001205 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI RYAN, ALLEN F. · 2013 to 2024
–
BLRD VA I01 BX001205NIDCD NIH HHS F31 DC012495NIDCD NIH HHS R01 DC000129NIDCD NIH HHS R01 DC012595NIDCD NIH HHS R03 DC014801U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders (NIDCD) DC014801U.S. Department of Veterans Affairs (VA) BX001205VA | Veterans Affairs San Diego Healthcare System (VA San Diego Healthcare System) BX001205
6 · The paper itself

Abstract

We previously identified peptides that are actively transported across the intact tympanic membrane (TM) of rats with infected middle ears. To assess the possibility that this transport would also occur across the human TM, we first developed and validated an assay to evaluate transport in vitro using fragments of the TM. Using this assay, we demonstrated the ability of phage bearing a TM-transiting peptide to cross freshly dissected TM fragments from infected rats or from uninfected rats, guinea pigs and rabbits. We then evaluated transport across fragments of the human TM that were discarded during otologic surgery. Human trans-TM transport was similar to that seen in the animal species. Finally, we found that free peptide, unconnected to phage, was transported across the TM at a rate comparable to that seen for peptide-bearing phage. These studies provide evidence supporting the concept of peptide-mediated drug delivery across the intact TM and into the middle ears of patients.

Indexed as

Biological AssayDrug Delivery SystemsPeptidesAnimalsBiological Transport, ActiveGuinea PigsHumansRabbitsRatsRats, Sprague-DawleyTympanic MembranePeptides

Identifiers

PMID30087425
PMCPMC6081404
OpenAlexW2888939647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.